Premium
Hypergonadotropic Hypogonadism in Newborn Males with Primary Testicular Failure
Author(s) -
DUNKEL L.,
PERHEENTUPA J.,
TAPANAINEN J.,
VIHKO R.
Publication year - 1984
Publication title -
acta pædiatrica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.772
H-Index - 115
eISSN - 1651-2227
pISSN - 0803-5253
DOI - 10.1111/j.1651-2227.1984.tb17768.x
Subject(s) - hypergonadotropic hypogonadism , medicine , endocrinology , luteinizing hormone , testosterone (patch) , follicle stimulating hormone , human chorionic gonadotropin , gonadotropin , basal (medicine) , sex organ , leydig cell , hormone , biology , insulin , genetics
. Four infants with genital ambiguity but with apparent testes were given a gonadotropin‐releasing hormone (GnRH) test and a human chorionic gonadotropin (hCG) test at age 3–12 days. The results were compared with those from 16 newborn males (aged 2 to 6 days) with minor genital anomalies; 9 with unilateral and 3 with bilateral incomplete testicular descent, 2 with surgically insignificant glandular hypospadias and 2 with penis length <(x̄‐2 SD) for gestational age. Treatment with testosterone resulted in clear phallus growth in all four patients. All four patients had elevated basal luteinizing hormone (LH) concentrations as well as an exaggerated LH response to GnRH; three of them also had an exaggerated follicle stimulating hormone (FSH) response. Thus in all patients the etiology of genital ambiguity was considered to be testicular. The testosterone response to hCG was normal in two of the patients but impaired in the other two. The steroidogenic response did not show any specific enzyme defect. We conclude that 1) newborn boys with Leydig cell failure are clearly hypergonadotropic, 2) the GnRH test is a more sensitive indicator of Leydig cell failure neonatally than the hCG test and 3) normal testes greatly inhibit the secretion of both LH and FSH during the first week of life.